miR-635 is under-expressed in gastric cancer, and its abnormal expression is significantly related to clinicopathological parameters such as increased TNM stage and lymph node metastasis, miR-635 inhibits the proliferation, migration, and invasion of gastric cancer cells by regulating kinesin family member C1 (KIFC1), which plays a role in inhibiting tumors [125]. Here, KIFC1 is linked to gastric cancer.